The miR-34 family in cancer and apoptosis

Cell Death and Differentiation

Volumn 17, Issue 2, 2010, Pages 193-199

  Hermeking, H ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

MicroRNA; MiR 34; MiR 34a; MiR 34b c; SIRT1

Indexed keywords

MICRORNA; MICRORNA 34; PROTEIN P53; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

APOPTOSIS; CANCER CELL; CANCER DIAGNOSIS; CANCER THERAPY; CELL CYCLE ARREST; CHRONIC LYMPHATIC LEUKEMIA; CPG ISLAND; DOWN REGULATION; GENE DELETION; GENE EXPRESSION REGULATION; GENE INACTIVATION; GENE TARGETING; GENETIC ANALYSIS; HUMAN; MALIGNANT NEOPLASTIC DISEASE; METHYLATION; MULTIGENE FAMILY; NEUROBLASTOMA; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN INDUCTION; REVIEW; SENESCENCE;

APOPTOSIS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 74249123570     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/cdd.2009.56     Document Type: Review

References (67)

1. Hollstein M, Sidransky D, Vogelstein B and Harris CC. p53 mutations in human cancers. Science 1991; 253: 49-53.
2. Soussi T. p53 alterations in human cancer: more questions than answers. Oncogene 2007; 26: 2145-2156.
3. Vogelstein B, Lane D and Levine AJ. Surfing the p53 network. Nature 2000; 408: 307-310.
4. Oren M. Decision making by p53: life, death and cancer. Cell Death Differ 2003; 10: 431-442.
5. Vousden KH and Lane DP. p53 in health and disease. Nat Rev Mol Cell Biol 2007; 8: 275-283.
6. Riley T, Sontag E, Chen P and Levine A. Transcriptional control of human p53-regulated genes. Nat Rev Mol Cell Biol 2008; 9: 402-412.
7. Aylon Y and Oren M. Living with p53, dying of p53. Cell 2007; 130: 597-600.
8. el-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R and Trent JM et al. WAF1, a potential mediator of p53 tumor suppression. Cell 1993; 75: 817-825.
9. Yu J, Zhang L, Hwang PM, Kinzler KW and Vogelstein B. PUMA induces the rapid apoptosis of colorectal cancer cells. Mol Cell 2001; 7: 673-682.
10. Hermeking H, Lengauer C, Polyak K, He TC, Zhang L and Thiagalingam S et al. 14-3-3 sigma is a p53-regulated inhibitor of G2/M progression. Mol Cell 1997; 1: 3-11.
11. Spurgers KB, Gold DL, Coombes KR, Bohnenstiehl NL, Mullins B and Meyn RE et al. Identification of cell cycle regulatory genes as principal targets of p53-mediated transcriptional repression. J Biol Chem 2006; 281: 25134-25142.
12. Ho J and Benchimol S. Transcriptional repression mediated by the p53 tumour suppressor. Cell Death Differ 2003; 10: 404-408.
13. Lohr K, Moritz C, Contente A and Dobbelstein M. p21/CDKN1A mediates negative regulation of transcription by p53. J Biol Chem 2003; 278: 32507-32516.
14. Budhram-Mahadeo V, Morris PJ, Smith MD, Midgley CA, Boxer LM and Latchman DS. p53 suppresses the activation of the Bcl-2 promoter by the Brn-3a POU family transcription factor. J Biol Chem 1999; 274: 15237-15244.
15. Valencia-Sanchez MA, Liu J, Hannon GJ and Parker R. Control of translation and mRNA degradation by miRNAs and siRNAs. Genes Dev 2006; 20: 515-524.
16. Peters L and Meister G. Argonaute proteins: mediators of RNA silencing. Mol Cell 2007; 26: 611-623.
17. Chen K and Rajewsky N. The evolution of gene regulation by transcription factors and microRNAs. Nat Rev Genet 2007; 8: 93-103.
18. Kloosterman WP and Plasterk RH. The diverse functions of microRNAs in animal development and disease. Dev Cell 2006; 11: 441-450.
19. Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell 2009; 136: 215-233.
20. Meister G and Tuschl T. Mechanisms of gene silencing by double-stranded RNA. Nature 2004; 431: 343-349.
21. Pillai RS, Bhattacharyya SN and Filipowicz W. Repression of protein synthesis by miRNAs: how many mechanisms? Trends Cell Biol 2007; 17: 118-126.
22. Lim LP, Lau NC, Garrett-Engele P, Grimson A, Schelter JM and Castle J et al. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 2005; 433: 769-773.
23. Garzon R, Fabbri M, Cimmino A, Calin GA and Croce CM. MicroRNA expression and function in cancer. Trends Mol Med 2006; 12: 580-587.
24. Cummins JM and Velculescu VE. Implications of micro-RNA profiling for cancer diagnosis. Oncogene 2006; 25: 6220-6227.
25. Esquela-Kerscher A and Slack FJ. Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer 2006; 6: 259-269.
26. Calin GA and Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer 2006; 6: 857-866.
27. Lee YS and Dutta A. MicroRNAs in cancer. Annu Rev Pathol 2009; 4: 199-227.
28. Johnson SM, Grosshans H, Shingara J, Byrom M, Jarvis R and Cheng A et al. RAS is regulated by the let-7 microRNA family. Cell 2005; 120: 635-647.
29. Mayr C, Hemann MT and Bartel DP. Disrupting the pairing between let-7 and Hmga2 enhances oncogenic transformation. Science 2007; 315: 1576-1579.
30. Yanaihara N, Caplen N, Bowman E, Seike M, Kumamoto K and Yi M et al. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 2006; 9: 189-198.
31. Chang TC, Wentzel EA, Kent OA, Ramachandran K, Mullendore M and Lee KH et al. Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol Cell 2007; 26: 745-752.
32. He L, He X, Lim LP, de Stanchina E, Xuan Z and Liang Y et al. A microRNA component of the p53 tumour suppressor network. Nature 2007; 447: 1130-1134.
33. Raver-Shapira N, Marciano E, Meiri E, Spector Y, Rosenfeld N and Moskovits N et al. Transcriptional activation of miR-34a contributes to p53-mediated apoptosis. Mol Cell 2007; 26: 731-743.
34. Tarasov V, Jung P, Verdoodt B, Lodygin D, Epanchintsev A and Menssen A et al. Differential regulation of microRNAs by p53 revealed by massively parallel sequencing: miR-34a is a p53 target that induces apoptosis and G1-arrest. Cell Cycle 2007; 6: 1586-1593.
35. Bommer GT, Gerin I, Feng Y, Kaczorowski AJ, Kuick R and Love RE et al. p53-mediated activation of miRNA34 candidate tumor-suppressor genes. Curr Biol 2007; 17: 1298-1307.
36. Corney DC, Flesken-Nikitin A, Godwin AK, Wang W and Nikitin AY. MicroRNA-34b and microRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth. Cancer Res 2007; 67: 8433-8438.
37. Hermeking H. p53 enters the microRNA world. Cancer Cell 2007; 12: 414-418.
38. Lodygin D, Tarasov V, Epanchintsev A, Berking C, Knyazeva T and Korner H et al. Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer. Cell Cycle 2008; 7: 2591-2600.
39. Collado M, Blasco MA and Serrano M. Cellular senescence in cancer and aging. Cell 2007; 130: 223-233.
40. Welch C, Chen Y and Stallings RL. MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells. Oncogene 2007; 26: 5017-5022.
41. Cole KA, Attiyeh EF, Mosse YP, Laquaglia MJ, Diskin SJ and Brodeur GM et al. A functional screen identifies miR-34a as a candidate neuroblastoma tumor suppressor gene. Mol Cancer Res 2008; 6: 735-742.
42. Fujita Y, Kojima K, Hamada N, Ohhashi R, Akao Y and Nozawa Y et al. Effects of miR-34a on cell growth and chemoresistance in prostate cancer PC3 cells. Biochem Biophys Res Commun 2008; 377: 114-119.
43. Ji Q, Hao X, Meng Y, Zhang M, Desano J and Fan D et al. Restoration of tumor suppressor miR-34 inhibits human p53-mutant gastric cancer tumorspheres. BMC Cancer 2008; 8: 266.
44. Sun F, Fu H, Liu Q, Tie Y, Zhu J and Xing R et al. Downregulation of CCND1 and CDK6 by miR-34a induces cell cycle arrest. FEBS Lett 2008; 582: 1564-1568.
45. Toyota M, Suzuki H, Sasaki Y, Maruyama R, Imai K and Shinomura Y et al. Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer. Cancer Res 2008; 68: 4123-4132.
46. Lujambio A, Calin GA, Villanueva A, Ropero S, Sanchez-Cespedes M and Blanco D et al. A microRNA DNA methylation signature for human cancer metastasis. Proc Natl Acad Sci USA 2008; 105: 13556-13561.
47. Pigazzi M, Manara E, Baron E and Basso G. miR-34b targets cyclic AMP-responsive element binding protein in acute myeloid leukemia. Cancer Res 2009; 69: 2471-2478.
48. Lewis BP, Shih IH, Jones-Rhoades MW, Bartel DP and Burge CB. Prediction of mammalian microRNA targets. Cell 2003; 115: 787-798.
49. Tazawa H, Tsuchiya N, Izumiya M and Nakagama H. Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells. Proc Natl Acad Sci USA 2007; 104: 15472-15477.
50. Li N, Fu H, Tie Y, Hu Z, Kong W and Wu Y et al. miR-34a inhibits migration and invasion by down-regulation of c-Met expression in human hepatocellular carcinoma cells. Cancer Lett 2009; 275: 44-53.
51. Yan D, Zhou X, Chen X, Hu DN, Dong XD and Wang J et al. MicroRNA-34a inhibits uveal melanoma cell proliferation and migration through downregulation of c-Met. Invest Ophthalmol Vis Sci 2009; 50: 1559-1565.
52. Migliore C, Petrelli A, Ghiso E, Corso S, Capparuccia L and Eramo A et al. MicroRNAs impair MET-mediated invasive growth. Cancer Res 2008; 68: 10128-10136.
53. Leucci E, Cocco M, Onnis A, De Falco G, van Cleef P and Bellan C et al. MYC translocation-negative classical Burkitt lymphoma cases: an alternative pathogenetic mechanism involving miRNA deregulation. J Pathol 2008; 216: 440-450.
54. Kong YW, Cannell IG, de Moor CH, Hill K, Garside PG and Hamilton TL et al. The mechanism of micro-RNA-mediated translation repression is determined by the promoter of the target gene. Proc Natl Acad Sci USA 2008; 105: 8866-8871.
55. Wei JS, Song YK, Durinck S, Chen QR, Cheuk AT and Tsang P et al. The MYCN oncogene is a direct target of miR-34a. Oncogene 2008; 27: 5204-5213.
56. Yamakuchi M, Ferlito M and Lowenstein CJ. miR-34a repression of SIRT1 regulates apoptosis. Proc Natl Acad Sci USA 2008; 105: 13421-13426.
57. Markey M and Berberich SJ. Full-length hdmX transcripts decrease following genotoxic stress. Oncogene 2008; 27: 6657-6666.
58. Leung AK and Sharp PA. microRNAs: a safeguard against turmoil? Cell 2007; 130: 581-585.
59. Cohen SM, Brennecke J and Stark A. Denoising feedback loops by thresholding\-a new role for microRNAs. Genes Dev 2006; 20: 2769-2772.
60. Kozaki K, Imoto I, Mogi S, Omura K and Inazawa J. Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in oral cancer. Cancer Res 2008; 68: 2094-2105.
61. Tryndyak VP, Ross SA, Beland FA and Pogribny IP. Down-regulation of the microRNAs miR-34a, miR-127, and miR-200b in rat liver during hepatocarcinogenesis induced by a methyl-deficient diet. Mol Carcinog 2008; [E-pub ahead of print]. doi: 10.1002/mc.20484.
62. Brooks CL and Gu W. How does SIRT1 affect metabolism, senescence and cancer? Nat Rev Cancer 2009; 9: 123-128.
63. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J and Peck D et al. MicroRNA expression profiles classify human cancers. Nature 2005; 435: 834-838.
64. Zenz T, Mohr J, Eldering E, Kater AP, Buhler A and Kienle D et al. MiR-34a as part of the chemotherapy resistance network in chronic lymphocytic leukemia. Blood 2009; 113: 3801-3808.
65. Mraz M, Malinova K, Kotaskova J, Pavlova S, Tichy B and Malcikova J et al. miR-34a, miR-29c and miR-17-5p are downregulated in CLL patients with TP53 abnormalities. Leukemia 2009; [E-pub ahead of print]. doi: 10.1038.
66. Kumamoto K, Spillare EA, Fujita K, Horikawa I, Yamashita T and Appella E et al. Nutlin-3a activates p53 to both down-regulate inhibitor of growth 2 and up-regulate mir-34a, mir-34b, and mir-34c expression, and induce senescence. Cancer Res 2008; 68: 3193-3203.
67. de Fougerolles A, Vornlocher HP, Maraganore J and Lieberman J. Interfering with disease: a progress report on siRNA-based therapeutics. Nat Rev Drug Discov 2007; 6: 443-453.